Avicanna Cannabis Products To Reach Australia Via Cannvalate Collaboration

Biopharmaceutical company Avicanna Inc. (TSX:AVCN) (OTC: AVCNF) has agreed to partner with Cannvalate Pty Ltd., an Australian medical cannabis-oriented B2B end-to-end solution provider.

The deal, signed Wednesday, includes an importation and distribution agreement where Avicanna will reach patients under the Australian Therapeutic Goods Administration Special Access Scheme with its Rho Phyto enhanced medical cannabis products.

In addition, the Ontario-based cannabis company also said it will provide Cannvalate with various CBD phytotherapeutic products on a white-labeled basis.

“After significant due diligence into the Australian market and its operators we are pleased …

Full story available on Benzinga.com

More Avicanna Cannabis Products To Reach Australia Via Cannvalate Collaboration